Drugs / (3S,4S,5R)-1,3,4,5,6-pentahydroxy-hexan-2-one
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06230900 | Feb 2024 → Apr 2025 | — | Wageningen University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | (3S,4S,5R)-1,3,4,5,6-pentahydroxy-hexan-2-one | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06230900 ↗ |
| Route | Oral | “Single oral administration study” NCT06230900 ↗ |